tiprankstipranks
Advertisement
Advertisement

SE:XSPRAY Stock Latest News

Xspray Pharma convenes 2026 AGM, sets voting rules and agenda
Company AnnouncementsXspray Pharma convenes 2026 AGM, sets voting rules and agenda
5d ago
Xspray Pharma launches SEK 83m rights issue to fund oncology pipeline
PremiumCompany Announcements
Xspray Pharma launches SEK 83m rights issue to fund oncology pipeline
14d ago
Xspray Pharma’s Rights Issue Oversubscribed and Over-Allotment Expanded
PremiumCompany Announcements
Xspray Pharma’s Rights Issue Oversubscribed and Over-Allotment Expanded
18d ago
Xspray Pharma Publishes Comprehensive Annual Report for 2025
PremiumCompany Announcements
Xspray Pharma Publishes Comprehensive Annual Report for 2025
19d ago
Xspray Pharma Launches SEK 83 Million Rights Issue to Fund Oncology Drug Launches
PremiumCompany Announcements
Xspray Pharma Launches SEK 83 Million Rights Issue to Fund Oncology Drug Launches
20d ago
Xspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
PremiumCompany AnnouncementsXspray Pharma Wins FDA Review Slot for Dasynoc Ahead of Planned 2026 Dual Launch
1M ago
Xspray Pharma Resubmits FDA Application for Leukemia Drug Dasynoc
Premium
Company Announcements
Xspray Pharma Resubmits FDA Application for Leukemia Drug Dasynoc
2M ago
Xspray Pharma installs new CEO as it pivots to commercial growth
Premium
Company Announcements
Xspray Pharma installs new CEO as it pivots to commercial growth
2M ago
Xspray Pharma Narrows 2025 Loss as FDA Sets Review Date for XS003
PremiumCompany Announcements
Xspray Pharma Narrows 2025 Loss as FDA Sets Review Date for XS003
2M ago
Xspray Pharma Achieves Key Milestones in Q3 2025
PremiumCompany Announcements
Xspray Pharma Achieves Key Milestones in Q3 2025
5M ago
Xspray Pharma’s XS003 NDA Accepted by FDA with PDUFA Date Set
PremiumCompany Announcements
Xspray Pharma’s XS003 NDA Accepted by FDA with PDUFA Date Set
6M ago
Xspray Pharma Announces Nomination Committee for 2026 AGM
PremiumCompany Announcements
Xspray Pharma Announces Nomination Committee for 2026 AGM
6M ago
Xspray Pharma Faces FDA Approval Delay for Dasynoc Due to Manufacturing Issues
PremiumCompany AnnouncementsXspray Pharma Faces FDA Approval Delay for Dasynoc Due to Manufacturing Issues
6M ago
Xspray Pharma Expands Share Base Amid High Investor Interest
Premium
Company Announcements
Xspray Pharma Expands Share Base Amid High Investor Interest
7M ago
Xspray Pharma’s Rights Issue Oversubscribed, Secures SEK 161 Million
Premium
Company Announcements
Xspray Pharma’s Rights Issue Oversubscribed, Secures SEK 161 Million
7M ago
Xspray Pharma Adjusts Rights Issue Trading Schedule
PremiumCompany Announcements
Xspray Pharma Adjusts Rights Issue Trading Schedule
8M ago
Xspray Pharma Secures Additional SEK 20 Million in Rights Issue
PremiumCompany Announcements
Xspray Pharma Secures Additional SEK 20 Million in Rights Issue
8M ago
Xspray Pharma Announces SEK 130 Million Rights Issue
PremiumCompany Announcements
Xspray Pharma Announces SEK 130 Million Rights Issue
8M ago
Xspray Pharma Advances Cancer Treatment with FDA Submission for XS003
PremiumCompany Announcements
Xspray Pharma Advances Cancer Treatment with FDA Submission for XS003
8M ago
Xspray Pharma Advances Towards U.S. Market with Dasynoc®
PremiumCompany AnnouncementsXspray Pharma Advances Towards U.S. Market with Dasynoc®
8M ago
Xspray Pharma Announces SEK 130 Million Rights Issue and Loan Refinancing
Premium
Company Announcements
Xspray Pharma Announces SEK 130 Million Rights Issue and Loan Refinancing
8M ago
Xspray Pharma Licenses Dasatinib Product to Handa Therapeutics
Premium
Company Announcements
Xspray Pharma Licenses Dasatinib Product to Handa Therapeutics
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >